AlzProtect's Series B Round

AlzProtect raised a round of funding on January 22, 2018.

AlzProtect is developing anti-Alzheimer drugs acting through an original mechanism of action and discovered in a collaborative work of several years at INSERM and the University of Lille 2. Its main l…

Articles about AlzProtect's Series B Round: